Literature DB >> 32449399

Barriers and motivators to pre-exposure prophylaxis uptake among Black and Latina transgender women in Los Angeles: perspectives of current PrEP users.

Omar Nieto1, Anne E Fehrenbacher2,3, Alejandra Cabral1,4, Amanda Landrian1,4, Ronald A Brooks1,2.   

Abstract

The purpose of this qualitative study was to identify barriers and motivators to PrEP uptake from the perspective of Black and Latina transgender women (TW) who are currently using PrEP to suggest intervention and outreach activities to increase PrEP uptake in this population. The Information-Motivation-Behavioral Skills Model guided the development of the semi-structured interview guide. A thematic analysis approach was used to analyze the data. Perceived barriers to PrEP uptake included structural and logistic barriers, language and cultural barriers to medical engagement, lack of transgender competent or gender-affirming care, and prioritizing hormone therapy over the use of PrEP. To increase PrEP uptake among BLTW, participants recommended disseminating PrEP information through a variety of methods, highlighting relationship and sexual health benefits of using PrEP, and developing effective patient-provider communication. Our findings highlight several ways to promote PrEP among BLTW. PrEP promotion should be integrated into gender-affirming care and supported by peer education and navigation services that reach BLTW in both clinic and community settings.

Entities:  

Keywords:  African American; Black; Latina; pre-exposure prophylaxis; transgender women

Mesh:

Substances:

Year:  2020        PMID: 32449399      PMCID: PMC7680715          DOI: 10.1080/09540121.2020.1769835

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  25 in total

1.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.

Authors:  Robert M Grant; Peter L Anderson; Vanessa McMahan; Albert Liu; K Rivet Amico; Megha Mehrotra; Sybil Hosek; Carlos Mosquera; Martin Casapia; Orlando Montoya; Susan Buchbinder; Valdilea G Veloso; Kenneth Mayer; Suwat Chariyalertsak; Linda-Gail Bekker; Esper G Kallas; Mauro Schechter; Juan Guanira; Lane Bushman; David N Burns; James F Rooney; David V Glidden
Journal:  Lancet Infect Dis       Date:  2014-07-22       Impact factor: 25.071

2.  Applying the Information-Motivation-Behavioral Skills Model to Understand PrEP Intentions and Use Among Men Who Have Sex with Men.

Authors:  Jennifer L Walsh
Journal:  AIDS Behav       Date:  2019-07

Review 3.  HIV pre-exposure prophylaxis (PrEP) awareness and acceptability among trans women: a review.

Authors:  Nathália Pacífico de Carvalho; Cássia Cristina Pinto Mendicino; Raissa Carolina Fonseca Cândido; Denyr Jeferson Dutra Alecrim; Cristiane Aparecida Menezes de Pádua
Journal:  AIDS Care       Date:  2019-05-01

4.  Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships.

Authors:  Ronald A Brooks; Rachel L Kaplan; Eli Lieber; Raphael J Landovitz; Sung-Jae Lee; Arleen A Leibowitz
Journal:  AIDS Care       Date:  2011-05-24

5.  Use of Pre-exposure Prophylaxis (PrEP) in Young Men Who Have Sex with Men is Associated with Race, Sexual Risk Behavior and Peer Network Size.

Authors:  Lisa M Kuhns; Anna L Hotton; John Schneider; Robert Garofalo; Kayo Fujimoto
Journal:  AIDS Behav       Date:  2017-05

6.  Uptake and effectiveness of PrEP for transgender women.

Authors:  Brandon D L Marshall; Matthew J Mimiaga
Journal:  Lancet HIV       Date:  2015-11-06       Impact factor: 12.767

7.  Predictors of PrEP Uptake Among Patients with Equivalent Access.

Authors:  Sarit A Golub; Rachel A Fikslin; Matthew H Goldberg; Stephanie M Peña; Asa Radix
Journal:  AIDS Behav       Date:  2019-07

8.  Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City.

Authors:  Christine Tagliaferri Rael; Michelle Martinez; Rebecca Giguere; Walter Bockting; Caitlin MacCrate; Will Mellman; Pablo Valente; George J Greene; Susan Sherman; Katherine H A Footer; Richard T D'Aquila; Alex Carballo-Diéguez
Journal:  AIDS Behav       Date:  2018-11

Review 9.  Worldwide burden of HIV in transgender women: a systematic review and meta-analysis.

Authors:  Stefan D Baral; Tonia Poteat; Susanne Strömdahl; Andrea L Wirtz; Thomas E Guadamuz; Chris Beyrer
Journal:  Lancet Infect Dis       Date:  2012-12-21       Impact factor: 25.071

Review 10.  Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review.

Authors:  Jeffrey H Herbst; Elizabeth D Jacobs; Teresa J Finlayson; Vel S McKleroy; Mary Spink Neumann; Nicole Crepaz
Journal:  AIDS Behav       Date:  2007-08-13
View more
  5 in total

1.  Brief Report: Transgender Women and Preexposure Prophylaxis Care: High Preexposure Prophylaxis Adherence in a Real-World Health Care Setting in New York City.

Authors:  Lila Starbuck; Sarit A Golub; Augustus Klein; Alexander B Harris; Amiyah Guerra; Christopher Rincon; Asa E Radix
Journal:  J Acquir Immune Defic Syndr       Date:  2022-05-01       Impact factor: 3.771

2.  Social Networks and Exchange Sex among Transgender Women.

Authors:  Anne E Fehrenbacher; Jesse B Fletcher; Kirsty A Clark; Kimberly A Kisler; Cathy J Reback
Journal:  J Sex Res       Date:  2021-03-28

3.  HIV Pre-exposure Prophylaxis Continuum of Care Among Transgender Individuals in an Integrated Health care System.

Authors:  J Carlo Hojilla; Leo B Hurley; Julia L Marcus; Derek D Satre; Michael J Silverberg; Eve F Zaritsky; Darios Getahun; Michael Goodman; Jonathan E Volk
Journal:  J Acquir Immune Defic Syndr       Date:  2022-03-01       Impact factor: 3.771

4.  Exploring barriers and facilitators to PrEP use among transgender women in two urban areas: implications for messaging and communication.

Authors:  Sarah Bauerle Bass; Patrick J Kelly; Jesse Brajuha; Luis Gutierrez-Mock; Kimberly Koester; Paul D'Avanzo; Jae Sevelius
Journal:  BMC Public Health       Date:  2022-01-06       Impact factor: 4.135

5.  Effects of Gender-Affirming Hormone Therapy on Progression Along the HIV Care Continuum in Transgender Women.

Authors:  Nathan A Summers; Trang T Huynh; Ruth C Dunn; Sara L Cross; Christian J Fuchs
Journal:  Open Forum Infect Dis       Date:  2021-07-30       Impact factor: 3.835

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.